Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISMN for Left Ventricular Hypertrophy in Hypertension
NCT01961453Phase 2Withdrawn
- Sponsor
- Corporal Michael J. Crescenz VA Medical Center
- Start
- Aug 2013
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of isosorbide mononitrate in hypertension (HTN) and left ventricular hypertrophy (LVH), sponsored by Corporal Michael J. Crescenz VA Medical Center. Planned start Aug 2013; status: withdrawn.
02
Drugs
isosorbide mononitrate
03
Conditions
hypertension (HTN)left ventricular hypertrophy (LVH)
Beyond the preview
Go deeper on NCT01961453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01961453.